Zolpidem for Persistent Insomnia in SSRItreated Depressed Patients, The Journal of Clinical Psychiatry, vol.60, issue.10, pp.668-676, 1999. ,
A Double-Blind, Randomized, Placebo-Controlled Trial of Augmentation With Lamotrigine or Placebo in Patients Concomitantly Treated With Fluoxetine for Resistant Major Depressive Episodes, The Journal of Clinical Psychiatry, vol.64, issue.4, pp.403-407, 2003. ,
DOI : 10.4088/JCP.v64n0407
Lithium Augmentation in Treatment-resistant Depression, 1999. ,
Lithium Augmentation in Treatment-resistant Depression, 2000. ,
Extended-release, 2013. ,
Lormetazepam in Depressive Insomnia: New Evidence of Phase-response Effects of Benzodiazepines Acceleration and Augmentation of Antidepressants with Lithium for Depressive Disorders: Two Meta-analyses of Randomized, Placebo-controlled Trials, International Clinical Psychopharmacology The Journal of Clinical Psychiatry, vol.68, issue.6, pp.935-940, 2004. ,
Carbamazepine for Treatment-resistant Melancholia, The Journal of Clinical Psychiatry, vol.52, issue.11, pp.472-476, 1991. ,
A Randomized, Double-blind, Placebo-controlled Trial of Pramipexole Augmentation in Treatment-resistant Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.74, issue.7, pp.636-641, 2013. ,
Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: a Placebo-and Duloxetine-controlled Study, The Journal of Clinical Psychiatry, vol.70, issue.4, pp.526-539, 2009. ,
Use of antidepressant combinations: which, when and why? Results of a Spanish survey, Acta Psychiatrica Scandinavica, vol.64, issue.1, pp.32-36, 2005. ,
DOI : 10.1016/S0197-2456(03)00112-0
The Efficacy of Divalproex Sodium in the Treatment of Agitation Associated With Major Depression, Journal of Clinical Psychopharmacology, vol.25, issue.5, pp.476-479, 2005. ,
DOI : 10.1097/01.jcp.0000177552.21338.b0
Quetiapine augmentation of treatment-resistant depression: a comparison with lithium, Current Medical Research and Opinion, vol.23, issue.2, pp.333-341, 2007. ,
DOI : 10.1185/030079906X162809
FDA Warns of Adverse Events Linked to Smoking Cessation Drug and Antiepileptics, JAMA, vol.299, issue.10, pp.1121-1122, 2008. ,
DOI : 10.1001/jama.299.10.1121
Outcome in Delusional Depression Comparing Trimipramine Monotherapy with a Combination of Amitriptyline and, 2009. ,
Arun V Ravindran, and Canadian Network for Mood and Anxiety Treatments (CANMAT), CANMAT) Clinical Guidelines for the Management, 2009. ,
Adjunctive Low-dose, 2011. ,
Efficacy and Tolerability of Selective Serotonin Reuptake Inhibitors Compared with Tricyclic Antidepressants in Depression Treated in Primary Care: Systematic Review and Meta-analysis, BMJ, p.326, 2003. ,
Risperidone for Treatment-refractory Major Depressive Disorder: a Randomized Trial, Annals of Internal Medicine, vol.147, issue.9, pp.593-602, 2007. ,
Placebo-controlled Trials, BMC Psychiatry, vol.12, issue.160 ,
Strategies for Managing Depression Refractory to Selective Serotonin Reuptake Inhibitor Treatment: A Survey of Clinicians, The Canadian Journal of Psychiatry, vol.43, issue.5, pp.476-481, 2000. ,
DOI : 10.1177/070674370004500509
A meta-analysis of the efficacy and tolerability of paroxetine versus tricyclic antidepressants in the treatment of major depression, International Clinical Psychopharmacology, vol.16, issue.3, pp.169-178, 2001. ,
DOI : 10.1097/00004850-200105000-00006
Which Antidepressants Have Demonstrated Superior Efficacy? A Review of the Evidence, International Clinical Psychopharmacology, vol.22, issue.6, pp.323-329, 2007. ,
Pooled Analysis of Two Large, Placebo-controlled Studies, Journal of Affective Disorders, vol.12013, pp.133-140 ,
Atypical Antipsychotic Augmentation in doi:10, 2009. ,
Hypnotics as concurrent medication in depression, Journal of Affective Disorders, vol.28, issue.3, pp.179-188, 1993. ,
DOI : 10.1016/0165-0327(93)90103-Q
Risperidone Augmentation of Selective Serotonin Reuptake Inhibitors in Major Depression, The Journal of Clinical Psychiatry, vol.60, issue.4, pp.256-259, 1999. ,
DOI : 10.4088/JCP.v60n0410
Atypical Antipsychotic Augmentation Strategies in the Context of Guideline-based Care for the Treatment of Major Depressive Disorder, CNS Drugs, vol.39, issue.8 Suppl. 2, pp.29-37, 2010. ,
DOI : 10.1007/s40263-012-0031-0
Effects of Risperidone Augmentation in Patients with Treatment-resistant Depression: Results of Open-label Treatment Followed by Double-blind Continuation Amisulpride in Medium-term Treatment of Dysthymia: a Six-month, Double-blind Safety Study Versus Amitriptyline. AMILONG Investigators, Neuropsychopharmacology: Official Ravizza Journal of Psychopharmacology, issue.3, pp.13-248, 1999. ,
Efficacy of Risperidone Augmentation to Antidepressants in the Management of Suicidality in Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.69, issue.8, pp.1228-1336, 2008. ,
DOI : 10.4088/JCP.v69n0805
A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder, Journal of Affective Disorders, vol.70, issue.3, pp.313-317, 2002. ,
DOI : 10.1016/S0165-0327(01)00327-5
A Double-Blind, Randomized Study of Olanzapine and Olanzapine/Fluoxetine Combination for Major Depression With Psychotic Features, Journal of Clinical Psychopharmacology, vol.24, issue.4, pp.365-373, 2004. ,
DOI : 10.1097/01.jcp.0000130557.08996.7a
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder, Neuropsychopharmacology, vol.19, issue.9, pp.1841-1853, 2006. ,
DOI : 10.1038/sj.npp.1301131
Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study, American Journal of Psychiatry, vol.168, issue.7, pp.689-701 ,
DOI : 10.1176/appi.ajp.2011.10111645
Bupropion-SR, Sertraline, or venlafaxine-XR after Failure of SSRIs for Depression, The New England Journal of Medicine, vol.354, issue.12, pp.1231-1242, 2006. ,
Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study, International Clinical Psychopharmacology, vol.22, issue.3, pp.179-182, 2007. ,
DOI : 10.1097/YIC.0b013e328014823d
Antidepressant Drugs: Indications and Guidelines for Use in Epilepsy, Epilepsia, vol.27, issue.2, pp.14-18, 2002. ,
DOI : 10.1046/j.1528-1157.2002.043s2014.x
Effect of Augmented Atypical Antipsychotics on Weight Change in Patients with Major Depressive Disorder in a Naturalistic Setting, Human Psychopharmacology, vol.24, issue.2, pp.135-143, 2009. ,
Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission A double-blind, comparative study, Journal of Affective Disorders, vol.48, issue.1, pp.47-56, 1998. ,
DOI : 10.1016/S0165-0327(97)00139-0
Compared with fluoxetine monotherapy, mirtazapine plus venlafaxine or fluoxetine increase remission but not response in patients with major depressive disorder, Evidence-Based Mental Health, vol.13, issue.3, 2010. ,
DOI : 10.1136/ebmh1061
A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.68, issue.02, pp.224-236, 2007. ,
DOI : 10.4088/JCP.v68n0207
Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report, American Journal of Psychiatry, vol.164, issue.5, pp.739-752, 2007. ,
DOI : 10.1176/ajp.2007.164.5.739
Medication Augmentation after the Failure of SSRIs for Depression, The New England Journal of Medicine, vol.354, issue.12, pp.1243-1252, 2006. ,
Clinical Results for Patients with Major Depressive Disorder in the Texas Medication Algorithm Project, Archives of General Psychiatry, vol.61, issue.7, pp.669-680, 2004. ,
Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice, American Journal of Psychiatry, vol.163, issue.1, pp.28-40, 2006. ,
DOI : 10.1176/appi.ajp.163.1.28
Benzodiazepine Use Among Depressed Patients Treated in Mental Health Settings, American Journal of Psychiatry, vol.161, issue.4, pp.654-661, 2004. ,
DOI : 10.1176/appi.ajp.161.4.654
The STAR*D Project Results: a Comprehensive Review of Findings, Current Psychiatry Reports, vol.9, issue.6, pp.449-459, 2007. ,
Analysis of Suicidality in Pooled Data from 2 Doubleblind , Placebo-controlled Aripiprazole Adjunctive Therapy Trials in Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.72, issue.4, pp.548-555, 2011. ,
Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence-Based Support from the Medical Literature, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol.352, issue.11, pp.344-359, 2013. ,
DOI : 10.1002/phar.1204
Algorithm-guided treatment versus treatment as usual for major depression, Psychiatry and Clinical Neurosciences, vol.12, issue.5, pp.652-657, 2009. ,
DOI : 10.1111/j.1440-1819.2009.02009.x